e-Drug3D

2142

FOSCARBIDOPA

INN
FOSCARBIDOPA

cas 1907685-81-7

CLASS

NERVOUS SYSTEM
TREATMENT OF MOTOR FLUCTUATIONS IN ADULTS WITH ADVANCED PARKINSON DISEASE
MAKES MORE LEVODOPA AVAILABLE TO THE BRAIN

ROUTE (list)

SUBCUTANEOUS

ATC code

PK parameters

PPB 25 PERCENT

Solubility

FREELY SOLUBLE IN WATER

Target

TARGET ALKALINE PHOSPHATASE

Download SDF file

Benzenepropanoic acid, alpha-hydrazinyl-3-hydroxy-alpha-methyl-4-(phosphonooxy)-, (alphaS)- (ACI)

Formula:
C10H15N2O7P

Calculated chemical properties:

MW 303.19
NB_atoms 20
XLogP -2.89
PSA 159.097
NB_HD 4
NB_HA 9
fsp3 0.30
Lipinski(0=no;1=yes) 0

FDA
NDA 216962 (pdf not found) INN (FOSCARBIDOPA ; FOSLEVODOPA) VYALEV (ABBVIE) APPROVAL= AP YEAR= 2024